home / stock / arqt / arqt news

ARQT News and Press, Arcutis Biotherapeutics Inc. From 01/02/24

Stock Information
Company Name: Arcutis Biotherapeutics Inc.
Stock Symbol: ARQT
Market: NASDAQ
Website: arcutis.com
Menu
ARQT ARQT Quote ARQT Short ARQT News ARQT Articles ARQT Message Board
Get ARQT Alerts

News, Short Squeeze, Breakout and More Instantly...
ARQT - SOFI, GH and IBRX are among after hour movers

2024-01-02 16:55:53 ET Gainers: Bloomin' Brands ( BLMN ) +6% . Arcutis Biotherapeutics ( ARQT ) +6% . Stronghold Digital Mining ( SDIG ) +5% . Longboard Pharmaceuticals ( LBPH ) +4% . Guardant Health ( GH ) +3% . Losers: ...
ARQT - COIN, CM, ARQT, BIL, FUSN showing five-day upward surge

2023-12-26 09:45:08 ET Coinbase Global Inc (COIN) COIN is trading UP for the last 5 days, and it at trading at $177.12 with volume of 3,974,731 and a one day change of $1.64 (0.93%). Coinbase Global Inc has a 52-week low of 32.58 and a 52-week high of $121.46. The business's 50-day ...

ARQT - Arcutis Biotherapeutics Inc. (NASDAQ: ARQT) is One of Monday Morning's Most Active Stocks

Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) is one today's most active stocks by volume. So far today, approximately 2.81M shares of Arcutis Biotherapeutics, Inc. have been exchanged, as compared to an average 30-day volume of 3.34M shares. Arcutis Biotherapeutics, Inc., a biopharmaceutical c...

ARQT - Arcutis stock rallies 28% in wake of FDA approval for dermatology drug

2023-12-18 10:39:54 ET More on Arcutis Biotherapeutics Arcutis Biotherapeutics: Almost There, But Needs Some Fine-Tuning Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation...
ARQT - Still Connecting- 24/7 Market News Snapshot 18 Dec 2023

2023-12-18 09:59:47 ET DENVER, Colo., Dec. 18, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual volume; Arcutis Biotherapeutics Inc (NASDAQ: ARQT), ZimVie Inc (NASDAQ: ZIMV), Safe & Green Development Corp (NAS...

ARQT - FDA Approval for the Treatment of Seborrheic Dermatitis has this Listing Popping

2023-12-18 07:29:52 ET DENVER, Colo., Dec 18, 2023 ( www.247marketnews.com )- Arcutis Biotherapeutics, Inc. (NASDAQ: ARQT) reported, after Friday’s market close, that the U.S. Food and Drug Administration (FDA) approved the new drug application (NDA) for ZORYVE (roflumilast) topi...

ARQT - Biggest stock movers today: Arcutis Biotherapeutics, Ebix and more

2023-12-18 06:09:25 ET Stock futures inched higher on Monday after the three major averages notched their seven-week winning streak Friday amid an indication that the Fed could slash interest rates at least three times next year and four cuts in 2025. Here ...
ARQT - Arcutis shares rally in after-hours trading on FDA approval

2023-12-15 19:02:32 ET More on Arcutis Biotherapeutics Arcutis Biotherapeutics: Almost There, But Needs Some Fine-Tuning Arcutis Biotherapeutics, Inc. (ARQT) Q3 2023 Earnings Call Transcript Arcutis Biotherapeutics, Inc. 2023 Q3 - Results - Earnings Call Presentation...

ARQT - FDA Approves Arcutis' ZORYVE® (roflumilast) Topical Foam, 0.3% for the Treatment of Seborrheic Dermatitis in Individuals Aged 9 Years and Older

ZORYVE foam represents a highly effective, safe, well-tolerated, once-daily steroid-free foam for use on all affected areas of the body, including hair-bearing areas, with no limitations on duration of use ZORYVE foam provides rapid disease clearance and significant reduction in itch, one of ...

ARQT - GOTU, SMR and LDI are among pre market gainers

2023-12-15 08:46:33 ET Aurora Technology Acquisition  ( ATAK ) +50% . Brilliant Acquisition  ( BRLI ) +27% . Ikena Oncology ( IKNA ) +24% . SportsMap Tech Acquisition  ( SMAP ) +14% . Pineapple Financial  ( PAPL ) +1%...
Previous 10 Next 10